Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Heitmann

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Diagnostics (Basel, Switzerland)|July 2, 2021
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?Yanjun Zhou, Jonas S Heitmann, Korbinian N Kropp, et al.
Journal of Leukocyte Biology|April 18, 2020
A novel flow cytometry-based assay to measure compromised B cell receptor signaling as a prognostic factor in chronic lymphocytic leukemiaJonas S Heitmann, Melanie Märklin, Felicia M Truckenmüller, et al.
Cancers|April 30, 2021
An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic LeukemiaFabian Riegg, Martina S Lutz, Bastian J Schmied, et al.
Journal for Immunotherapy of Cancer|June 1, 2020
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodiesJoseph Kauer, Sebastian Hörner, Lukas Osburg, et al.
Journal of Visualized Experiments : Jove|December 25, 2018
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic LeukemiaAlexander R Fuchs, Melanie Märklin, Jonas S Heitmann, et al.
Immunotargets and Therapy|May 7, 2026
B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile CancerAleksander Kielbik, Veronika Bahlinger, Christian M Schürch, et al.
Blood Cancer Journal|April 18, 2024
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibodySylwia A Stefańczyk, Ilona Hagelstein, Martina S Lutz, et al.
Frontiers in Oncology|April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer ProgressionClemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Frontiers in Immunology|April 11, 2025
CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemiaBoris Klimovich, Leonard Anton, Jinwon Jung, et al.
Frontiers in Immunology|September 28, 2020
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic LeukemiaMelanie Märklin, Alexander R Fuchs, Claudia Tandler, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Diagnostics (Basel, Switzerland)|July 2, 2021
Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?Yanjun Zhou, Jonas S Heitmann, Korbinian N Kropp, et al.
Journal of Leukocyte Biology|April 18, 2020
A novel flow cytometry-based assay to measure compromised B cell receptor signaling as a prognostic factor in chronic lymphocytic leukemiaJonas S Heitmann, Melanie Märklin, Felicia M Truckenmüller, et al.
Cancers|April 30, 2021
An Fc-Optimized CD133 Antibody for Induction of NK Cell Reactivity against B Cell Acute Lymphoblastic LeukemiaFabian Riegg, Martina S Lutz, Bastian J Schmied, et al.
Journal for Immunotherapy of Cancer|June 1, 2020
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodiesJoseph Kauer, Sebastian Hörner, Lukas Osburg, et al.
Journal of Visualized Experiments : Jove|December 25, 2018
A Chromatin Immunoprecipitation Assay to Identify Novel NFAT2 Target Genes in Chronic Lymphocytic LeukemiaAlexander R Fuchs, Melanie Märklin, Jonas S Heitmann, et al.
Immunotargets and Therapy|May 7, 2026
B7-H3 (CD276) as Target for T Cell-Based Bispecific Antibody Therapy of Penile CancerAleksander Kielbik, Veronika Bahlinger, Christian M Schürch, et al.
Blood Cancer Journal|April 18, 2024
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibodySylwia A Stefańczyk, Ilona Hagelstein, Martina S Lutz, et al.
Frontiers in Oncology|April 5, 2021
Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer ProgressionClemens Hinterleitner, Yanjun Zhou, Claudia Tandler, et al.
Frontiers in Immunology|April 11, 2025
CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemiaBoris Klimovich, Leonard Anton, Jinwon Jung, et al.
Frontiers in Immunology|September 28, 2020
Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic LeukemiaMelanie Märklin, Alexander R Fuchs, Claudia Tandler, et al.
Pageof 8